MODULATION OF TYPE-1 PROTEIN PHOSPHATASE BY SYNTHETIC PEPTIDES CORRESPONDING TO THE CARBOXYL TERMINUS

被引:18
|
作者
MARTIN, BL [1 ]
SHRINER, CL [1 ]
BRAUTIGAN, DL [1 ]
机构
[1] BROWN UNIV,DIV BIOL & MED,BIOCHEM SECT,PROVIDENCE,RI 02912
关键词
PHOSPHATASE SPECIFICITY; OKADAIC ACID; PEPTIDE ANTIBODY; MYOSIN LIGHT CHAIN;
D O I
10.1016/0014-5793(91)80712-C
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein phosphatase type-1 (PP-1) has a protease resistant catalytic core M(r) = 35 000 (PP-35K) and a carboxyl terminal segment which affects activity with various substrates. We found that micromolar concentration of a synthetic peptide, corresponding to residues 312-326 of the PP-1 carboxyl terminus (P312-326) that is missing from PP-35K, increased the phosphatase activity of PP-35K with phosphorylase and myosin light chains as substrates by decreasing the apparent K(m) without a change in V(m). Purified PP-1 and PP-35K were inhibited identically by okadaic acid, but peptide P312-326 only stimulated the activity of PP-35K, not full-length PP-1. Other peptides corresponding to the carboxyl terminus of phosphatase-2A or to the amino terminus of PP-1 did not affect the activity of PP-35K. A sequence conserved in PP-1 from different species, Pro-Ile-Thr-Pro-Pro was implicated as the active region because a derivative peptide, Ala-Pro-Ile-Thr-Pro-Pro-Ala, stimulated the activity of PP-35K to the same extent as peptide P312-326 although at higher concentrations. These results indicate that the carboxyl terminus of PP-1 interacts with the catalytic core to modulate its activity, and suggest that the physiological regulation of PP-1 may involve this segment.
引用
收藏
页码:6 / 10
页数:5
相关论文
共 50 条
  • [31] EXPRESSION AND SUBCELLULAR-LOCALIZATION OF THE GLYCOGEN-ASSOCIATED TYPE-1 PROTEIN PHOSPHATASE
    KUNTZ, MJ
    DEPAOLIROACH, AA
    [J]. FASEB JOURNAL, 1993, 7 (07): : A1156 - A1156
  • [32] THE MECHANISM OF ACTIVATION OF PROTEIN-KINASE FA (THE ACTIVATOR OF TYPE-1 PROTEIN PHOSPHATASE) IN BRAIN SYNAPTOSOMES
    YANG, SD
    YU, JS
    FONG, YL
    LIU, JS
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 182 (01) : 129 - 136
  • [33] Alterations in the Interactome of Serine/Threonine Protein Phosphatase Type-1 in Atrial Fibrillation Patients
    Chiang, David Y.
    Lebesgue, Nicolas
    Beavers, David L.
    Alsina, Katherina M.
    Damen, J. Mirjam A.
    Voigt, Niels
    Dobrev, Dobromir
    Wehrens, Xander H. T.
    Scholten, Arjen
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (02) : 163 - 173
  • [34] CO-PURIFICATION OF TYPE-1 ALKALINE-PHOSPHATASE AND TYPE-1 PHOSPHOPROTEIN PHOSPHATASE FROM VARIOUS ANIMAL-TISSUES
    LI, HC
    CHAN, WWS
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1981, 207 (02) : 270 - 281
  • [35] Carboxyl terminus heterogeneity of type IV fimbrial subunit protein of Pasteurella multocida isolates
    Shivachandra, Sathish Bhadravati
    Kumar, Abhinendra
    Yogisharadhya, Revanaiah
    Ramakrishnan, M. A.
    Viswas, K. N.
    [J]. VETERINARY RESEARCH COMMUNICATIONS, 2013, 37 (04) : 269 - 275
  • [36] Carboxyl terminus heterogeneity of type IV fimbrial subunit protein of Pasteurella multocida isolates
    Sathish Bhadravati Shivachandra
    Abhinendra Kumar
    Revanaiah Yogisharadhya
    M. A. Ramakrishnan
    K. N. Viswas
    [J]. Veterinary Research Communications, 2013, 37 : 269 - 275
  • [37] SEQUENCE OF MOUSE ADENOVIRUS TYPE-1 DNA ENCODING THE AMINO TERMINUS OF PROTEIN IVA2
    KRING, SC
    SPINDLER, KR
    [J]. NUCLEIC ACIDS RESEARCH, 1990, 18 (13) : 4003 - 4003
  • [38] Immunogenicity of synthetic peptides corresponding to the nonrepeat regions of the Plasmodium falciparum circumsporozoite protein
    Lopez, JA
    Renggli, J
    Eberl, G
    Corradin, G
    Roggero, MA
    Gonzalez, JM
    Arevalo, M
    Herrera, S
    Tolle, R
    Bujard, H
    Betschart, B
    Koita, O
    Doumbo, O
    [J]. VACCINES 96 - MOLECULAR APPROACHES TO THE CONTROL OF INFECTIOUS DISEASES, 1996, : 255 - 260
  • [39] INVOLVEMENT OF A TYPE-1 PROTEIN PHOSPHATASE ENCODED BY BWS1+ IN FISSION YEAST MITOTIC CONTROL
    BOOHER, R
    BEACH, D
    [J]. CELL, 1989, 57 (06) : 1009 - 1016
  • [40] Antibody response to protein peptides and polysaccharide antigens inpatients with type-1 and type-2 diabetes
    Hink, S
    Eibl, NL
    Wolf, H
    Schernthaner, G
    Eibl, MM
    [J]. DIABETOLOGIA, 1999, 42 : A97 - A97